WB; IHC, Frozen; ELISA; Neut, Neutralizing IHC, ELISA, WB, inhibition of biological activity. A concentration of 1-10 μg/mL is recommended for IHC, ELISA, WB and inhibition of biological activity in vitro; 2-10 μg/mL (ED50) for in vivo use. Biosensis recommends optimal dilutions/concentrations should be determined by the end user.
免疫原
A synthetic peptide (YAEHKSHRGEY) as part of human, mouse and rat NT3 protein conjugated to BSA has been used as the immunogen.
來源宿主
綿羊
反應(yīng)性
This antiserum is known to react with 大鼠, 雞, 人 NT3.